Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Jayasree K. Iyer to discuss the future of bNAbs in HIV prevention

Jayasree K. Iyer, CEO of the Access to Medicine Foundation, has been invited to share her expertise as a panelist in a webinar series organised by the IAS Governing Council and the HIVR4P 2024 Organizing Committee. Jayasree will delve into the landscape of HIV prevention research, focusing on the vital role of broadly neutralising antibodies (bNAbs).

Date

16 October 2023

Date

16 October 2023

Format

Virtual

In an exciting lead-up to the HIV Research for Prevention Conference (HIVR4P) 2024, Jayasree K. Iyer is set to take the virtual stage as a panelist in a webinar series hosted by the IAS Governing Council and the HIVR4P 2024 Organizing Committee. These webinars serve as a platform for distinguished experts like Jayasree to share insights and engage in impactful discussions surrounding the challenges in biomedical prevention. 

As Jayasree and fellow panelists join the virtual conversation, their contributions will help shed light on the future trajectory of HIV prevention research, while expanding the collective knowledge of groundbreaking strategies that have the potential to bring us closer to a world free from the burden of HIV. 

Drawing from her role as the CEO of the Foundation, Jayasree will also emphasise the importance of ensuring the availability and accessibility of biomedical prevention to people living in low- and middle-income countries, where HIV prevalence is most pronounced. 

Resource Centre

Explore our research reports and publications

Implementing strong access strategies across different country income classifications

15 November 2022

Accompanying licensing agreements with technology transfers to manufacturers

15 November 2022
Research

Ending the burden of HIV, malaria and TB in children

09 June 2020

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved